466. Deputy Cormac Devlin asked the Minister for Health further to Parliamentary Question No. 460 of 27 September 2022, the current status of the application for pricing and reimbursement of a medication (details supplied) for the treatment of primary hypercholesterolaemia and mixed dyslipidaemia; whether the HSE has received a revised commercial offer or a new application from the marketing authorisation holder since the NCPE assessment of March 2022; whether the application has been considered by the HSE Drugs Group, and the outcome; and the routes by which patients for whom inclisiran is clinically indicated can currently access it. [69605/26]

Summary

466. Deputy Cormac Devlin asked the Minister for Health further to Parliamentary Question No. 460 of 27 September 2022, the current status of the application for pricing and reimbursement of a medication (details supplied) for the treatment of primary hypercholesterolaemia and mixed dyslipidaemia; whether the HSE has received a revised commercial offer or a new application from the marketing authorisation holder since the NCPE assessment of March 2022; whether the application has been considered by the HSE Drugs Group, and the outcome; and the routes by which patients for whom inclisiran is clinically indicated can currently access it. [69605/26]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 1 October 2026

   Medicinal Products

   466. Deputy Cormac Devlin asked the Minister for Health further to Parliamentary Question No. 460 of 27 September 2022, the current status of the application for pricing and reimbursement of a medication (details supplied) for the treatment of primary hypercholesterolaemia and mixed dyslipidaemia; whether the HSE has received a revised commercial offer or a new application from the marketing authorisation holder since the NCPE assessment of March 2022; whether the application has been considered by the HSE Drugs Group, and the outcome; and the routes by which patients for whom inclisiran is clinically indicated can currently access it. [69605/26]

   Source: written

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 1 October 2026

  ViewDownloadOpen at official source

Sponsors

• Cormac Devlin · Asking member
• Health · Health · Addressed to

Related records

No cross-record relationships stored yet.